Schedule 13G ownership disclosure

Ovid therapeutics, Inc.

Security class unavailable · CUSIP: 690469101

Event date: 2018-12-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,370,000
Percent of class
5.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001170316-19-000001
Form type
SC 13G
Filer
Ovid Therapeutics Inc.
CIK
CIK 1636651
Filed
Jan 04, 2019
Reporting period
Dec 27, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub